Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: Behavioral, neurochemical and immunohistochemical studies

Brain Research

Volumn 1368, Issue , 2011, Pages 254-263

  Khuwaja, Gulrana ^a,b   Khan, Mohd Moshahid ^a,c   Ishrat, Tauheed ^a,d   Ahmad, Ajmal ^a   Raza, Syed Shadab ^a   Ashafaq, Mohammad ^a   Javed, Hayate ^a   Khan, M Badruzzaman ^a   Khan, Andleeb ^a   Vaibhav, Kumar ^a   Safhi, Mohammed M ^b   Islam, Fakhrul ^a,b  

^a HAMDARD UNIVERSITY   (India)

^b JAZAN UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF IOWA   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 Hydroxydopamine; Behavior; Dopamine D2 receptors; Immunohistochemistry; Oxidative stress; Parkinson's disease

Indexed keywords

APOMORPHINE; ASCORBIC ACID; CATALASE; CURCUMIN; DOPAMINE 2 RECEPTOR; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID; OXIDOPAMINE; SUPEROXIDE DISMUTASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIET; GRIP STRENGTH; IMMUNOHISTOCHEMISTRY; INDIA; LIPID PEROXIDATION; MALE; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; ROTAROD TEST; SHAM PROCEDURE;

ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; CURCUMIN; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSONIAN DISORDERS; RATS; RATS, WISTAR; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; CURCUMA LONGA; PARKINSONIA; RATTUS;

EID: 78651068527     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.10.023     Document Type: Article

References (55)

1. A.K. Agrawal, R. Hussin, R. Raghubir, A. Kumar, and P.K. Seth Neurobehavioral, neurochemical and electrophysiological studies in 6-hydroxydopamine lesioned and neural transplanted rats Int. J. Dev. Neurosci. 13 1995 105 111
2. M. Ahmad, S. Saleem, A.S. Ahmad, M.A. Ansari, S. Yousuf, M.N. Hoda, and F. Islam Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats Hum. Exp. Toxicol. 24 2005 1 11
3. M. Ahmad, S. Saleem, A.S. Ahmad, S. Yousuf, M.A. Ansari, M.B. Khan, T. Ishrat, R.K. Chaturvedi, A.K. Agrawal, and F. Islam Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences J. Neurochem. 93 2005 94 104
4. M. Ahmad, S. Saleem, A.S. Ahmad, M.A. Ansari, S. Yousuf, and M.N. Hoda Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats Hum. Exp. Toxicol. 24 3 2005 137 147
5. M. Ahmad, S. Yousuf, M.B. Khan, S. Saleem, T. Ishrat, Md.N Hoda, and F. Islam Protective effects of ethanolic extract of Delphinium denudatum in a rat model of Parkinson's disease Human Expt. Toxicol. 25 7 2006 361 368
6. H.N. Allbutt, and J.M. Henderson Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease J. Neurosci. Methods 159 2007 195 202
7. A. Ataie, M. Sabetkasaei, A. Haghparast, A.H. Moghaddam, R. Ataee, and S.N. Moghaddam Curcumin exerts neuroprotective effects against homocysteine intracerebroventricular injection-induced cognitive impairment and oxidative stress in rat brain J. Med. Food 13 2010 821 826
8. K. Bala, B.C. Tripathy, and D. Sharma Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions Biogerontology 7 2 2006 81 89
9. J.S. Beckman, T.W. Beckman, and J. Chen Apparent hydroxyl radical production by peroxynitrite implications for endothelial injury from nitric oxide and superoxide Proc. Natl Acad. Sci. USA 87 1990 1620 1624 duction
10. A.N. Begum, M.R. Jones, G.P. Lim, T. Morihara, P. Kim, and D.D. Heath Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease J. Pharmacol. Exp. Ther. 326 1 2008 196 208
11. M. Bishnoi, K. Chopra, and S.K. Kulkarni Protective effect of curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain Pharmacol. Biochem. Behav. 88 4 2008 511 522
12. C.R. Breese, and G.R. Breese The use of neurotoxin to lesion catecholamine neurons to model clinical disorder Kostrzewa Rm, Highly Selective Neurotoxin: Basic and Clinical Application 1998 Humana Press New Jersey 19 73
13. A. Caliborne R.A. Green Wald, Catalase activity CRC Hand Book of Methods for Oxygen Radical Research 1985 CRC Press Boca Raton, FL 283 284
14. R.K. Chaturvedi, S. Shukla, K. Seth, S. Chauhan, C. Sinha, Y. Shukla, and A.K. Agrawal Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease Neurobiol. Dis. 22 2006 421 434
15. I. Carlberg, and B. Mannervik Glutathione reductase levels in rat brain J. Biol. Chem. 250 1975 5475 5480
16. G. Cohen, and R.E. Heikkila The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents J. Biol. Chem. 249 1974 2447 2452
17. +-ATPase J. Supramol. Struct. 13 1980 165 174
18. P. Dohare, P. Garg, V. Jain, C. Nath, and M. Ray Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat Behav. Brain Res. 193 2 2008 289 297
19. J. Fornaguera, R.K.W. Schwarting, F. Boix, and J.P. Huston Behavioral indices of moderate nigro-striatal 6-hydroxydopamine lesion: a preclinical Parkinson's model Synapse 13 1993 179 185
20. B.A. Freeman, and J.D. Crapo Biology of disease: free radicals and tissue injury Lab. Invest. 47 1982 412 426
21. (+)-ATPase activity and beta-endorphin content in acute ischemic brain with and without naloxone treatment J. Neurosurg. 72 1990 458 462
22. M. Ganguli, V. Chandra, M.I. Kamboh, J.M. Johnston, H.H. Dodge, B.K. Thelma, R.C. Juyal, R. Pandav, S.H. Belle, and S.T. DeKosky Apolipoprotein E polymorphism and Alzheimer disease: the Indo-US Cross-National Dementia Study Arch. Neurol. 57 6 2000 824 830
23. B. Halliwell, and J.M.C. Gutteridge Oxygen radicals and the nervous system Trends Neurosci. 8 1985 22 29
24. (+2) ATPase and lipid peroxidation and early ultrastructural findings following middle cerebral artery occlusion in the rat Acta Neurochir (Wien) 138 1996 338 345
25. S.Z. Imam, and S.F. Ali Selenium an antioxidant attenuates methamphetamine indiced dopaminergic toxicity and peroxynitrile generation Brain Res. 855 2000 186 191
26. T. Ishrat, M.N. Hoda, M.B. Khan, S. Yousuf, M. Ahmad, M.M. Khan, A. Ahmad, and F. Islam Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT) Eur. Neuropsychopharmacol. 19 9 2009 636 647
27. F. Islam, S. Zia, I. Sayeed, K.S. Zafar, and A.S. Ahmad Selenium-induced alteration of lipids, lipid peroxidation, thiol group circadian rhythm centers of rat Biol. Trace Elem. Res. 90 2002 203 214
28. N. Jha, O. Jurma, G. Lalli, Y. Liu, E.H. Pettus, J.T. Greenamyre, R.M. Liu, H.J. Forman, and J.K. Andersen Glutathione depletion in PC12 results in selective inhibition of mitochondrial dihydoxyvitamin D3- and ATRA-induced differentiation of human promyelocytic leukemia HL-60 cells Eur. J. Pharmacol. 420 2000 83 90
29. F. Jin, Q. Wu, Y.F. Lu, Q.H. Gong, and J.S. Shi Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats Eur. J. Pharmacol. 600 2008 78 82
30. D.J. Jollow, J.R. Mitchell, N. Zampagloine, and J.R. Gillete Bromobenzene-induced liver necrosis: protective role of glutathione and evidence for 3,4 bromobenzeneoxide as the hepatotoxic intermediate 1974
31. M. Kale, N. Rathore, S. John, and D. Bhatnagar Lipid peroxidative damage on pyrethroid exposure and alterations in antioxidant status in rat erythrocytes: a possible involvement of reactive oxygen species Toxicol Lett. 105 1999 197 205 (Pubitemid 29164489)
32. 2 dopamine receptor deficient mice in determined by gene dosage, genetic background and development adaptations J. Neurosci. 18 1998 7470 7479
33. A. Kuhad, and K. Chopra Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences Eur. J. Pharmacol. 576 1-3 2007 34 42
34. C.S. Lee, H. Sauer, and A. Bjorklund Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat Neuroscience 72 1996 641 653
35. O.H. Lowry, N.J. Rosebrought, A.L. Farr, and R.J. Randal Protein measurement with Folin phenol reagent J. Biol. Chem. 193 1951 265 275
36. J. Mohandas, J.J. Marshall, G.G. Duggin, J.S. Horvath, and D. Tiller Differential distribution of glutathione and glutathione related enzymes in rabbit kidneys: possible implication in analgesic neuropathy Cancer Res. 44 1984 5086 5091
37. P.M. Moran, L.S. Higgins, B. Cordell, and P.C. Moser Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein Proc. Natl Acad. Sci. USA 92 12 1995 5341 5345
38. M. Orth, and A.H. Schapira Mitochondrial involvement in Parkinson's disease Neurochem. Int. 40 6 2002 533 541
39. T. Osawa, M. Namiki, and S. Kawakishi Role of dietary antioxidants in protection against oxidative damage Basic Life Sci. 52 1990 139 153
40. G. Paxinos, and C. Watson The Rat Brain Stereotaxic Coordinates 1981 Academic Press Sydney
41. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 4th ed. 1982 Academic Press California, USA
42. D.J. Reed Glutathione: toxicological implications Annu. Rev. Pharmacol. Toxicol. 30 1990 603 631
43. R.K. Schwarting, A.E. Bonatz, R.J. Carey, and J.P. Huston Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections Brain Res. 554 1991 46 55
44. R.K.W. Schwarting, and J.L. Hudson The unilateral 6-OHDA injection lesion model in behaviour brain research: analysis of functional deficit, recovery and treatment Prog. Neurobiol. 50 1996 275 331
45. R.A. Sharma, A.J. Gescher, and W.P. Steward Curcumin: the story so far Eur. J. Cancer 41 13 2005 1955 1968 Review
46. N. Sreejayan, and M.N. Rao Free radical scavenging activity of curcuminoids Arzneimittelforschung 46 2 1996 169 171
47. M. Stevens, I. Obrosova, X. Cao, C.V. Huysen, and D.A. Green Effects of dl-alpa-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism and oxidative, blood flow, energy metabolism and oxidative stress in experimental diabetic neuropathy Diabetes 49 2000 1006 1015
48. Y. Sun Free radicals, antioxidant enzymes, and carcinogenesis Free Radic. Biol. Med. 8 1990 583 599
49. M. Thiyagarajan, and S.S. Sharma Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats Life Sci. 74 8 2004 969 985
50. U. Ungerstedt 6-Hydroxy-dopamine induced degeneration of central dopamine neurons Eur. J. Pharmacol. 5 1968 107 110
51. H.C. Utley, F. Bernheim, and P. Hochslein Effect of sulfhydryl reagent on peroxidation in microsome Arch. Biochem. Biophys. 260 1967 521 531
52. J.J. Vanderhaeghen, O. Périer, and J.E. Sternon Pathological findings in idiopathic orthostatic hypotension. Its relationship with Parkinson's disease Arch. Neurol. 22 3 1970 207 214
53. I.Q. Whishaw, K. Li, P.A. Whishaw, B. Gorny, and G.A. Metz Use of rotorod as a method for the qualitative analysis of walking in rat J. Vis. Exp. 22 2008 pii: 1030
54. K.S. Zafar, I. Sayeed, A. Siddiqui, M. Ahmad, S. Salim, and F. Islam Dose-dependent protective effect of selenium in partial lesion model of Parkinson's disease: neurobehavioral and neurochemical evidences J. Neurochem. 84 2003 438 446 (Pubitemid 36182242)
55. M.G. Ziegler, and H. Szechtman Relation between motor asymmetry and direction of rotational behaviour under amphetamine and apomorphine in rats with unilateral degeneration of the nigrostriatal dopamine system Behav. Brain Res. 39 1990 123 133